User profiles for N. Bolli

Niccolo Bolli

University of Milan
Verified email at unimi.it
Cited by 23823

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

B Falini, MP Martelli, N Bolli… - Blood, The Journal …, 2011 - ashpublications.org
After the discovery of NPM1-mutated acute myeloid leukemia (AML) in 2005 and its subsequent
inclusion as a provisional entity in the 2008 World Health Organization classification of …

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications

B Falini, N Bolli, A Liso, MP Martelli, R Mannucci… - Leukemia, 2009 - nature.com
… One is found within residues 94–102 with the sequence I-xx-P-xx-L-x-L 13 and the other at
the N-terminus within amino acids 42 to 49 (sequence L-x-L-xx-V-x-L), with leucines 42 and …

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

B Falini, I Nicoletti, N Bolli, MP Martelli, A Liso… - haematologica, 2007 - air.unimi.it
… In the encoded NPM-MLF1 fusion protein, the N-terminal portion of NPM is fused to almost
the entire MLF1 protein, excluding only the first 16 amino acids at the N-terminus96 (Figure 1B…

Signatures of mutational processes in human cancer

…, S Behjati, AV Biankin, GR Bignell, N Bolli… - Nature, 2013 - nature.com
All cancers are caused by somatic mutations; however, understanding of the biological
processes generating these mutations is limited. The catalogue of somatic mutations from a …

[HTML][HTML] Genomic classification and prognosis in acute myeloid leukemia

…, NE Potter, M Heuser, F Thol, N Bolli… - … England Journal of …, 2016 - Mass Medical Soc
Background Recent studies have provided a detailed census of genes that are mutated in
acute myeloid leukemia (AML). Our next challenge is to understand how this genetic diversity …

[HTML][HTML] Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

N Bolli, H Avet-Loiseau, DC Wedge, P Van Loo… - Nature …, 2014 - nature.com
… Two (n=13) or three (n=2) serial samples were available for 15 patients. Fifteen patients were
sampled … The fraction of cells bearing each mutation was then calculated as n mut /n chr . …

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

…, L Alexandrov, S Behjati, LR Yates, N Bolli… - Science, 2014 - science.org
Introduction The human genome is peppered with mobile repetitive elements called long
interspersed nuclear element–1 (L1) retrotransposons. Propagating through RNA and cDNA …

[HTML][HTML] A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

…, J Obenauer, M Trotter, D Auclair, J Keats, N Bolli… - Leukemia, 2019 - nature.com
n = 784 dataset, since for this analysis, presence of ISS was not required. c OS in the same
set of patients (n = 863) … Note that this dataset is larger than the n = 784 dataset, since for this …

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

…, E Papaemmanuil, G Gundem, A Shlien, N Bolli… - elife, 2014 - elifesciences.org
n = 49); mutations in the metastasis not found in the primary (n = 49); and shared mutations
(n … drift (VAF difference >0.2) between the two samples (n = 25). These data, particularly the …

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

…, M Trotter, D Auclair, J Keats, N Bolli… - Blood, The Journal …, 2018 - ashpublications.org
Understanding the profile of oncogene and tumor suppressor gene mutations with their
interactions and impact on the prognosis of multiple myeloma (MM) can improve the definition of …